INVO Fertility, Inc (IVF) vs Nexalin Technology, Inc. (NXL)
INVO Fertility, Inc and Nexalin Technology, Inc. are both Medical Devices companies. INVO Fertility, Inc is the larger, with a market value of $4.4M against $3.6M — 1.2× the size. Nexalin Technology, Inc. has negative trailing earnings, so its P/E is not meaningful; INVO Fertility, Inc trades at 0.0×. Nexalin Technology, Inc. grew revenue faster over the last twelve months: 24.3% against 13.8%. INVO Fertility, Inc has the higher net margin (−116.3% vs −4,138.5%) and the higher return on invested capital (−27.9% vs −1,108.8%). Across the 18 metrics below, INVO Fertility, Inc leads on 13 and Nexalin Technology, Inc. on 5.
Valuation
Profitability
| Metric | IVF | NXL | Medical Devices median |
|---|---|---|---|
| Gross margin | 35.28% | 86.14% | 56.01% |
| Operating margin | (78.72%) | (4,201.66%) | (15.03%) |
| Net margin | (116.30%) | (4,138.49%) | (20.40%) |
| Free cash flow margin | (63.97%) | (2,917.96%) | (7.24%) |
| Return on equity | (203.65%) | (240.25%) | (15.32%) |
| Return on assets | (38.79%) | (187.89%) | (19.72%) |
| Return on invested capital | (27.92%) | (1,108.82%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack